Smith & Nephew (LON:SN) Stock Price Passes Above 200 Day Moving Average of $1,061.05

Smith & Nephew plc (LON:SN) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,061.05 ($14.21) and traded as high as GBX 1,157 ($15.49). Smith & Nephew shares last traded at GBX 1,151.50 ($15.42), with a volume of 708,297 shares traded.

Analyst Ratings Changes

Separately, Berenberg Bank restated a “buy” rating and issued a £145 ($194.16) price target on shares of Smith & Nephew in a research report on Monday, August 5th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,956.20 ($52.98).

Smith & Nephew Stock Up 0.1 %

The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The stock’s 50 day simple moving average is GBX 1,158.42 and its 200 day simple moving average is GBX 1,061.05. The firm has a market cap of £10.04 billion, a P/E ratio of 4,428.85, a price-to-earnings-growth ratio of 0.47 and a beta of 0.62.

Smith & Nephew Cuts Dividend

The business also recently declared a dividend, which will be paid on Friday, November 8th. Investors of record on Thursday, October 3rd will be issued a dividend of $0.14 per share. The ex-dividend date is Thursday, October 3rd. This represents a yield of 1%. Smith & Nephew’s dividend payout ratio (DPR) is currently 11,538.46%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.